Swiss TPH TB researchers in Bagamayo, Tanzania. Multi-drug resistance makes it necessary for people carrying these bacteria to be isolated and undergo treatment with multiple drugs at a hospital for up to two years.
Migration increases the risk of tuberculosis outbreaks in populations. The Swiss Tropical and Public Health Institute (Swiss TPH) contributed to the development of a pan-European alert system and the documentation of a cross-border response to an outbreak of multidrug-resistant tuberculosis - one of the most common pathogens in humans. Tuberculosis (TB), an infectious disease with a high global morbidity and mortality, is one of the top ten causes of death worldwide, killing an estimated 1.7 million people annually. Pan-European Alert System Global migration increases the risk of TB outbreaks in populations, also in Europe. Swiss TPH contributed to a recent analysis of the development of a pan-European alert system and the detailed documentation of a cross-border response to an outbreak of multidrug-resistant Mycobacterium tuberculosis - one of the most common pathogens in humans. The molecular epidemiological study, a wide transnational European investigation led by the University of Zurich and the Swiss National Mycobacterial Reference Laboratory, was published in The Lancet Infectious Diseases. It compiled epidemiological data from host countries of the European Centre for Disease Prevention and Control (ECDC) and interviewed a group of patients with multidrug-resistant TB who had arrived in Europe from the Horn of Africa and Sudan.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
